Episode 17

Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville discusses emerging evidence with proteolysis-targeting chimera estrogen receptor degraders for HR-positive metastatic breast cancer.

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Breast Cancer Update
Breast Cancer Update
This series bridges the gap between research and patient care by providing on-going access to the perspectives and opinions of national and international breast cancer research leaders.

Listen for free